CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.90 +0.06 (+6.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Income - Equity (2022 - 2025)

Updated

CytoMed Therapeutics' Income - Equity came in at -$4,931 for Q4 2025.

Analysis

CytoMed Therapeutics (GDTC) Income - Equity (2022 - 2025) Analysis & Trends

For FY2025, CytoMed Therapeutics' Income - Equity was -$4,892.

  • Going back by year, Income - Equity was $10,305 in FY2024, -$23,237 in FY2023, -$24,342 in FY2022 and $2,024 in FY2021.
  • The Q4 2025 figure represents the lowest quarterly Income - Equity since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income - Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 CytoMed Therapeutics 9.94 Mn -1.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -4,931.15
Dec 31, 2023 -23,108.12
Dec 31, 2022 -24,171.97
API Access

CytoMed Therapeutics Income - Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-equity&ticker=GDTC&period=max&api_key=YOUR_API_KEY